RX-10045

· Resolvyx Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RX-10045, covering 2010-09-24 to 2013-02-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RX-10045 in the Treatment of Dry Eye Disease [Phase 2]